PerkinElmer completed the acquisition of Covaris from New Mountain Capital.

PerkinElmer, a global analytical services and solutions provider, completed the acquisition of Covaris, a developer of solutions to empower life science innovations, from New Mountain Capital, a private equity firm. Financial terms were not disclosed. "Covaris has a well-defined growth strategy with market-leading technologies and a very capable leadership team that will allow PerkinElmer to deepen its life sciences portfolio in the diagnostics end market. We see significant growth opportunities resulting from the combined resources of both companies, with PerkinElmer’s global scale unlocking commercial opportunities for Covaris," Dirk Bontridder, PerkinElmer CEO.